Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors
Tsukada, T., Takahashi, M., Takemoto, T., Kanno, O., Yamane, T., Kawamura, S., Nishi, T.(2009) Bioorg Med Chem Lett 19: 5909-5912
- PubMed: 19762234 
- DOI: https://doi.org/10.1016/j.bmcl.2009.08.081
- Primary Citation of Related Structures:  
3A29 - PubMed Abstract: 
With the aim of discovering a novel class of fructose-1,6-bisphosphatase (FBPase) inhibitors, a series of compounds based on tricyclic scaffolds was synthesized. Extensive SAR studies led to the finding of 8l with an IC50 value of 0.013 microM against human FBPase. An X-ray crystallographic study revealed that 8l bound at AMP binding sites of human liver FBPase with hydrogen bonding interactions similar to AMP.
Organizational Affiliation: 
Medicinal Chemistry Research Laboratories I, Daiichi Sankyo Co., Ltd, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.